145 related articles for article (PubMed ID: 29126735)
1. Design, synthesis and evaluation of amino-substituted 1H-phenalen-1-ones as anti-leishmanial agents.
Freijo MB; López-Arencibia A; Piñero JE; McNaughton-Smith G; Abad-Grillo T
Eur J Med Chem; 2018 Jan; 143():1312-1324. PubMed ID: 29126735
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and anti-leishmanial activity of novel symmetrical bispyridinium cyclophanes.
Gómez-Pérez V; Manzano JI; García-Hernández R; Castanys S; Gamarro F; Campos JM
Eur J Med Chem; 2015 Jan; 89():362-9. PubMed ID: 25462252
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antileishmanial activity of C7- and C12-functionalized dehydroabietylamine derivatives.
Dea-Ayuela MA; Bilbao-Ramos P; Bolás-Fernández F; González-Cardenete MA
Eur J Med Chem; 2016 Oct; 121():445-450. PubMed ID: 27318121
[TBL] [Abstract][Full Text] [Related]
4. New phenalenone analogues with improved activity against Leishmania species.
López-Arencibia A; Bethencourt-Estrella CJ; Freijo MB; Reyes-Batlle M; Sifaoui I; Nicolás-Hernández DS; McNaughton-Smith G; Lorenzo-Morales J; Abad-Grillo T; Piñero JE
Biomed Pharmacother; 2020 Dec; 132():110814. PubMed ID: 33086179
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of piperazinyl-β-carbolinederivatives as anti-leishmanial agents.
Ashok P; Chander S; Smith TK; Sankaranarayanan M
Eur J Med Chem; 2018 Apr; 150():559-566. PubMed ID: 29549840
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of 1H-phenalen-1-one derivatives against Leishmania spp. and evidence of programmed cell death.
López-Arencibia A; Reyes-Batlle M; Freijo MB; Sifaoui I; Bethencourt-Estrella CJ; Rizo-Liendo A; Chiboub O; McNaughton-Smith G; Lorenzo-Morales J; Abad-Grillo T; Piñero JE
Parasit Vectors; 2019 Dec; 12(1):601. PubMed ID: 31870406
[TBL] [Abstract][Full Text] [Related]
7. Anti-Leishmanial and Cytotoxic Activities of a Series of Maleimides: Synthesis, Biological Evaluation and Structure-Activity Relationship.
Fan Y; Lu Y; Chen X; Tekwani B; Li XC; Shen Y
Molecules; 2018 Nov; 23(11):. PubMed ID: 30400596
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and in-vitro anti-leishmanial activity of (4-arylpiperazin-1-yl)(1-(thiophen-2-yl)-9H-pyrido[3,4-b]indol-3-yl)methanone derivatives.
Ashok P; Chander S; Chow LM; Wong IL; Singh RP; Jha PN; Sankaranarayanan M
Bioorg Chem; 2017 Feb; 70():100-106. PubMed ID: 27939960
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of New Cyclic Imides Derived from Safrole, Structure- and Ligand-based Approaches to Evaluate Potential New Multitarget Agents Against Species of Leishmania.
de Sousa Luis JA; da Silva Costa NA; Luis CCS; Lira BF; Athayde-Filho PF; de Souza Lima TK; da Câmara Rocha J; Scotti L; Scotti MT
Med Chem; 2020; 16(1):39-51. PubMed ID: 31208311
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of aryl pyrimidine derivatives as potential leishmanicidal agents.
Suryawanshi SN; Kumar S; Shivahare R; Pandey S; Tiwari A; Gupta S
Bioorg Med Chem Lett; 2013 Sep; 23(18):5235-8. PubMed ID: 23910597
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of novel triazolyl quinoline derivatives as potential antileishmanial agents.
Upadhyay A; Kushwaha P; Gupta S; Dodda RP; Ramalingam K; Kant R; Goyal N; Sashidhara KV
Eur J Med Chem; 2018 Jun; 154():172-181. PubMed ID: 29793211
[TBL] [Abstract][Full Text] [Related]
12. Biological evaluation and structure activity relationship of 9-methyl-1-phenyl-9H-pyrido[3,4-b]indole derivatives as anti-leishmanial agents.
Ashok P; Chander S; Smith TK; Prakash Singh R; Jha PN; Sankaranarayanan M
Bioorg Chem; 2019 Mar; 84():98-105. PubMed ID: 30500524
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and pharmacological evaluation of mono-arylimidamides as antileishmanial agents.
Zhu X; Farahat AA; Mattamana M; Joice A; Pandharkar T; Holt E; Banerjee M; Gragg JL; Hu L; Kumar A; Yang S; Wang MZ; Boykin DW; Werbovetz KA
Bioorg Med Chem Lett; 2016 May; 26(10):2551-2556. PubMed ID: 27048943
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antikinetoplastid activities of 3-substituted quinolinones derivatives.
Audisio D; Messaoudi S; Cojean S; Peyrat JF; Brion JD; Bories C; Huteau F; Loiseau PM; Alami M
Eur J Med Chem; 2012 Jun; 52():44-50. PubMed ID: 22472166
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy of leishmaniasis. Part IX: synthesis and bioevaluation of aryl substituted ketene dithioacetals as antileishmanial agents.
Kumar S; Tiwari A; Suryawanshi SN; Mittal M; Vishwakarma P; Gupta S
Bioorg Med Chem Lett; 2012 Nov; 22(21):6728-30. PubMed ID: 23031588
[TBL] [Abstract][Full Text] [Related]
16. In vitro 4-Aryloxy-7-chloroquinoline derivatives are effective in mono- and combined therapy against Leishmania donovani and induce mitocondrial membrane potential disruption.
Valdivieso E; Mejías F; Torrealba C; Benaim G; Kouznetsov VV; Sojo F; Rojas-Ruiz FA; Arvelo F; Dagger F
Acta Trop; 2018 Jul; 183():36-42. PubMed ID: 29604246
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of 1,3,6-trisubstituted β-carboline derivatives for cytotoxic and anti-leishmanial potential.
Lunagariya NA; Gohil VM; Kushwah V; Neelagiri S; Jain S; Singh S; Bhutani KK
Bioorg Med Chem Lett; 2016 Feb; 26(3):789-794. PubMed ID: 26791014
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, structure-activity relationships, and biological studies of chromenochalcones as potential antileishmanial agents.
Shivahare R; Korthikunta V; Chandasana H; Suthar MK; Agnihotri P; Vishwakarma P; Chaitanya TK; Kancharla P; Khaliq T; Gupta S; Bhatta RS; Pratap JV; Saxena JK; Gupta S; Tadigoppula N
J Med Chem; 2014 Apr; 57(8):3342-57. PubMed ID: 24635539
[TBL] [Abstract][Full Text] [Related]
19. Anti-plasmodial and anti-leishmanial activity of conformationally restricted pentamidine congeners.
Huang TL; Vanden Eynde JJ; Mayence A; Donkor IO; Khan SI; Tekwani BL
J Pharm Pharmacol; 2006 Aug; 58(8):1033-42. PubMed ID: 16872549
[TBL] [Abstract][Full Text] [Related]
20. In vitro evaluation of traditionally used Surinamese medicinal plants for their potential anti-leishmanial efficacy.
Mans DR; Beerens T; Magali I; Soekhoe RC; Schoone GJ; Oedairadjsingh K; Hasrat JA; van den Bogaart E; Schallig HD
J Ethnopharmacol; 2016 Mar; 180():70-7. PubMed ID: 26778603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
